GO
Loading...

Allergan Inc

More

  • Oct 20- Allergan Inc shareholder Paulson& Co is urging the Botox maker to merge with specialty pharmaceutical company Shire Plc as an alternative to a deal with hostile bidder Valeant Pharmaceuticals, according to two people familiar with the matter. The hedge fund told Allergan CEO David Pyott that it would support a deal with Shire, the sources said.

  • Report: Paulson pushing Allergan-Shire merger     Monday, 20 Oct 2014 | 12:15 PM ET

    According to Reuters sources, Allergan shareholder John Paulson is urging the company to merge with Shire. CNBC's Dominic Chu has the details.

  • Oct 20- Valeant Pharmaceuticals International Inc said on Monday that it may raise its bid for Botox maker Allergan Inc after the Canadian company posted a better-than-expected quarterly profit. Allergan stock was up 1.7 percent at $180.45. Valeant's third-quarter results were keenly anticipated for their potential impact on Valeant's bid for Allergan,...

  • Early Glance: Medical Devices companies Monday, 20 Oct 2014 | 10:40 AM ET

    Allergan rose $3.01 or 1.7 percent, to $180.50. Baxter International Inc. rose$. 02 or percent, to $67.26. Boston Scientific Corp. rose$. 05 or. 4 percent, to $11.42.

  • Oct 20- Valeant Pharmaceuticals Inc Chief Executive Michael Pearson said in an interview with Reuters on Monday that he is confident a revised bid for Allergan Inc will be worth over $200 per share, once Valeant's stock rises and with cash added to the offer. Pearson said Valeant could make a revised offer at any time and that the company's stock has been hurt by...

  • Oct 20- Canada's Valeant Pharmaceuticals International Inc, embroiled in a bitter fight to take over Botox maker Allergan Inc, posted a better-than-expected quarterly profit, driven by demand for its skin, neuro and eye drugs. The company also raised its full-year adjusted earnings forecast to $8.22- $8.32 per share from $7.90- $8.10 per share to reflect its...

  • Valeant's bid for Allergan     Monday, 20 Oct 2014 | 7:22 AM ET

    Michael Pearson, Valeant Pharmaceuticals CEO, shares his thoughts on allegations Allergan released false and misleading information.

  • Final Glance: Medical Devices companies Friday, 17 Oct 2014 | 6:03 PM ET

    Allergan fell$. 51 or. 3 percent, to $177.49. Baxter International Inc. fell$. 94 or 1.4 percent, to $67.24. Boston Scientific Corp. fell$. 08 or. 7 percent, to $11.37.

  • Midday Glance: Medical Devices companies Friday, 17 Oct 2014 | 1:21 PM ET

    Allergan fell $2.34 or 1.3 percent, to $175.66. Baxter International Inc. fell$. 35 or. 5 percent, to $67.83. Boston Scientific Corp. fell$. 01 or. 1 percent, to $11.44.

  • Early Glance: Medical Devices companies Friday, 17 Oct 2014 | 10:39 AM ET

    Allergan fell$. 06 or percent, to $177.94. Baxter International Inc. fell$. 47 or. 7 percent, to $67.71. Boston Scientific Corp. fell$. 03 or. 3 percent, to $11.42.

  • Final Glance: Medical Devices companies Thursday, 16 Oct 2014 | 6:02 PM ET

    Allergan rose$. 41 or. 2 percent, to $178.00. Baxter International Inc. fell$. 16 or. 2 percent, to $68.18. Boston Scientific Corp. rose$. 01 or. 1 percent, to $11.45.

  • Midday Glance: Medical Devices companies Thursday, 16 Oct 2014 | 1:21 PM ET

    Allergan fell$. 04 or percent, to $177.56. Baxter International Inc. rose$. 65 or 1.0 percent, to $68.99. Boston Scientific Corp. rose$. 02 or. 2 percent, to $11.46.

  • CNBC's Scott Wapner reports investor Bill Ackman says he has new information that Allergan tried to manipulate Valeant's stock price lower with false information.

  • Early Glance: Medical Devices companies Thursday, 16 Oct 2014 | 11:35 AM ET

    Allergan fell $4.39 or 2.5 percent, to $173.20. Baxter International Inc. fell $1.01 or 1.5 percent, to $67.33. Boston Scientific Corp. fell$. 12 or 1.0 percent, to $11.33.

  • *AbbVie board recommends shareholders vote against deal. *AbbVie to pay Shire $1.64 bln break fee if deal collapses. LONDON, Oct 16- U.S. drugmaker AbbVie has pulled the plug on its plan to buy Dublin- based Shire, recommending shareholders vote against the planned $55 billion takeover following new U.S. tax rules.

  • Final Glance: Medical Devices companies Wednesday, 15 Oct 2014 | 6:07 PM ET

    Allergan fell $4.40 or 2.4 percent, to $177.59. Baxter International Inc. fell$. 52 or. 8 percent, to $68.34. Boston Scientific Corp. fell$. 12 or 1.0 percent, to $11.44.

  • Midday Glance: Medical Devices companies Wednesday, 15 Oct 2014 | 1:17 PM ET

    Allergan fell $8.30 or 4.6 percent, to $173.69. Baxter International Inc. fell $1.69 or 2.5 percent, to $67.17. Boston Scientific Corp. fell$. 32 or 2.7 percent, to $11.25.

  • Early Glance: Medical Devices companies Wednesday, 15 Oct 2014 | 10:46 AM ET

    Allergan fell $5.93 or 3.3 percent, to $176.06. Baxter International Inc. fell $1.10 or 1.6 percent, to $67.76. Boston Scientific Corp. fell$. 13 or 1.1 percent, to $11.43.

  • Final Glance: Medical Devices companies Tuesday, 14 Oct 2014 | 6:03 PM ET

    Allergan rose $3.71 or 2.1 percent, to $181.99. Baxter International Inc. fell$. 80 or 1.1 percent, to $68.86. Boston Scientific Corp. fell$. 18 or 1.5 percent, to $11.56.

  • Midday Glance: Medical Devices companies Tuesday, 14 Oct 2014 | 1:42 PM ET

    Allergan rose $2.64 or 1.5 percent, to $180.92. Baxter International Inc. rose$. 01 or percent, to $69.67. Boston Scientific Corp. rose$. 02 or. 2 percent, to $11.76.